Barely Significant
← all phrases

“an elevated trend”

279 sentences · 279 papers · 514 search hits before verification · confirmed specimen

Sighted at

p<0.05

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

an elevated trendP = 3.71 × 10 −130.0× alphagold
In addition, we found evidence of high GNA12 expression in multiple sets of colorectal RNA-seq data ( GSE107593 : P = 7.48 × 10 −9 , LogFC = 0.42; GSE117993 : P = 6.76 × 10 −7 , LogFC = 0.27; GSE166925 : P = 1.09 × 10 −3 , LogFC = 0.52) and suggested an elevated trend in myeloid cells ( GSE162335 : P = 3.71 × 10 −13 , LogFC = 0.42).
an elevated trendp < 0.0010.0× alphagold
Further subgroup analyses disclosed that in PASI75 responders, miR‐146a expression also showed an elevated trend throughout these four time points ( p < 0.001) (Figure 3B ); while in non‐PASI75 responders, the increasing trend of miR‐146a expression was not significant throughout these four time points ( p = 0.124) (Figure 3C ).
an elevated trendP < 0.010.2× alphagold
The results showed that the expression of c-kit mRNA and SCF mRNA in the tail-hanging group was significantly lower compared with that in the control group ( P < 0.0001; P < 0.001), and the expression of c-kit mRNA and SCF mRNA in the tail-hanging group presented a trend of elevation with significant difference ( P < 0.01), and that in the tail-hanging group the expression of SCF mRNA in the probiotics The expression of SCF mRNA in the tail-hanging group showed an elevated trend with significant difference ( P < 0.01), The expression of c-kit mRNA in the probiotic tail-hanging group showed an elevated trend, but there was no significant difference ( P > 0.05; Figure 2 ).
an elevated trendP < 0.051.0× alphagold
Interestingly, butyrylcarnitine (C4) showed an elevated trend in the GR group after probiotic supplementation ( P < 0.05 by the Wilcoxon signed-rank test; Supplementary Fig. 7 and Supplementary Table 8 ), which is consistent with our early report that butyrylcarnitine (C4) was increased in older women supplemented with L. reuteri ATCC PTA 6475 compared to placebo 16 .
an elevated trendP = 0.07181.4× alphagold
No significant difference in serum FGF-21 levels was observed between CHD patients with hypertension (462.2 ng/l, [59.1–2614.9], n = 97) and CHD patients without hypertension (428.2 ng/l, [77.8–1069.2] n = 38), despite an elevated trend in these CHD patients with hypertension (P = 0.0718, Figure 1C ).